Matches in SemOpenAlex for { <https://semopenalex.org/work/W22473413> ?p ?o ?g. }
Showing items 1 to 80 of
80
with 100 items per page.
- W22473413 endingPage "5" @default.
- W22473413 startingPage "S11" @default.
- W22473413 abstract "Interleukin-6 (IL-6) is a pleiotropic cytokine, present at elevated levels in patients with rheumatoid arthritis (RA). Il-6 signaling involves both a specific IL-6 receptor (IL-6R) and a ubiquitous signal-transducing protein, gp130 that is also utilized by other members of the IL-6 family. Il-6 signaling occurs by two mechanisms. Conventional signaling involves the binding of IL-6 to transmembrane IL-6R on cells expressing this receptor. In contrast, trans-signaling involves binding between the complex of soluble IL-6R/IL-6 and membrane-bound gp130. Trans-signaling allows IL-6 to affect cells that do not express IL-6R, including many synovial cells. The biological activities of IL-6 contribute to both systemic and local RA symptoms. Il-6 is a strong inducer of the acute-phase response, which can result in fever, secondary amyloidosis, anemia, and elevations in acute-phase proteins, such as C-reactive protein (CRP). The ability of IL-6 to induce B-cell differentiation may lead to the formation of rheumatoid factor and other autoantibodies. In joints, IL-6 promotes osteoclast activation and induces the release of matrix metalloproteinases, thus contributing to joint damage. In patients with RA, IL-6 levels correlate with markers of disease activity and clinical symptoms, and animal studies support the concept that this cytokine plays a role in the development of inflammatory arthritis. Clinical trials with tocilizumab, a humanized monoclonal antibody to soluble IL-6R, have shown that blocking IL-6 signaling reduces RA symptoms and markers of disease activity. Current evidence thus strongly supports the association between IL-6 and RA symptoms and suggests that IL-6 blockade will be a useful therapeutic strategy for patients with this disease." @default.
- W22473413 created "2016-06-24" @default.
- W22473413 creator A5059516590 @default.
- W22473413 date "2007-01-01" @default.
- W22473413 modified "2023-10-05" @default.
- W22473413 title "Interleukin-6--a key mediator of systemic and local symptoms in rheumatoid arthritis." @default.
- W22473413 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/17708739" @default.
- W22473413 hasPublicationYear "2007" @default.
- W22473413 type Work @default.
- W22473413 sameAs 22473413 @default.
- W22473413 citedByCount "52" @default.
- W22473413 countsByYear W224734132012 @default.
- W22473413 countsByYear W224734132013 @default.
- W22473413 countsByYear W224734132014 @default.
- W22473413 countsByYear W224734132015 @default.
- W22473413 countsByYear W224734132016 @default.
- W22473413 countsByYear W224734132017 @default.
- W22473413 countsByYear W224734132018 @default.
- W22473413 countsByYear W224734132019 @default.
- W22473413 countsByYear W224734132021 @default.
- W22473413 countsByYear W224734132022 @default.
- W22473413 countsByYear W224734132023 @default.
- W22473413 crossrefType "journal-article" @default.
- W22473413 hasAuthorship W22473413A5059516590 @default.
- W22473413 hasConcept C11988809 @default.
- W22473413 hasConcept C126037660 @default.
- W22473413 hasConcept C159654299 @default.
- W22473413 hasConcept C163764329 @default.
- W22473413 hasConcept C200155923 @default.
- W22473413 hasConcept C203014093 @default.
- W22473413 hasConcept C2777178219 @default.
- W22473413 hasConcept C2777575956 @default.
- W22473413 hasConcept C2778690821 @default.
- W22473413 hasConcept C62478195 @default.
- W22473413 hasConcept C71924100 @default.
- W22473413 hasConcept C86803240 @default.
- W22473413 hasConcept C95444343 @default.
- W22473413 hasConceptScore W22473413C11988809 @default.
- W22473413 hasConceptScore W22473413C126037660 @default.
- W22473413 hasConceptScore W22473413C159654299 @default.
- W22473413 hasConceptScore W22473413C163764329 @default.
- W22473413 hasConceptScore W22473413C200155923 @default.
- W22473413 hasConceptScore W22473413C203014093 @default.
- W22473413 hasConceptScore W22473413C2777178219 @default.
- W22473413 hasConceptScore W22473413C2777575956 @default.
- W22473413 hasConceptScore W22473413C2778690821 @default.
- W22473413 hasConceptScore W22473413C62478195 @default.
- W22473413 hasConceptScore W22473413C71924100 @default.
- W22473413 hasConceptScore W22473413C86803240 @default.
- W22473413 hasConceptScore W22473413C95444343 @default.
- W22473413 hasLocation W224734131 @default.
- W22473413 hasOpenAccess W22473413 @default.
- W22473413 hasPrimaryLocation W224734131 @default.
- W22473413 hasRelatedWork W1779691448 @default.
- W22473413 hasRelatedWork W1895277992 @default.
- W22473413 hasRelatedWork W2012942026 @default.
- W22473413 hasRelatedWork W2022502525 @default.
- W22473413 hasRelatedWork W2022713850 @default.
- W22473413 hasRelatedWork W2063485775 @default.
- W22473413 hasRelatedWork W2069473482 @default.
- W22473413 hasRelatedWork W2084386397 @default.
- W22473413 hasRelatedWork W2086840459 @default.
- W22473413 hasRelatedWork W2093252878 @default.
- W22473413 hasRelatedWork W2096862304 @default.
- W22473413 hasRelatedWork W2114308202 @default.
- W22473413 hasRelatedWork W2117521006 @default.
- W22473413 hasRelatedWork W2125212735 @default.
- W22473413 hasRelatedWork W2139339400 @default.
- W22473413 hasRelatedWork W2150952126 @default.
- W22473413 hasRelatedWork W2152348310 @default.
- W22473413 hasRelatedWork W2182371873 @default.
- W22473413 hasRelatedWork W2892663691 @default.
- W22473413 hasRelatedWork W46650105 @default.
- W22473413 hasVolume "65 Suppl 1" @default.
- W22473413 isParatext "false" @default.
- W22473413 isRetracted "false" @default.
- W22473413 magId "22473413" @default.
- W22473413 workType "article" @default.